In a new report released Monday, the White House accused the Biden Administration of overseeing what it described as a “grotesque social and scientific experiment” on America’s children.

According to the report, during President Biden’s first three years in office, more than 7,000 minors were administered puberty blockers and cross-sex hormones, and over 4,000 underwent sex-trait modification surgeries, including mastectomies. That comes to over 3.5 sexual mutilation surgeries on children every day of the Biden Administration.

The White House characterized these interventions as ideologically driven and financially motivated, citing a lack of rigorous scientific foundation. This is a promise that President Trump made before he took office — to end the growing practice of child genital mutilation, also known as transgender surgery.

The report is the first formal update on the implementation of President Trump’s Executive Order 14187, titled “Protecting Children from Chemical and Surgical Mutilation,” signed on Jan. 28.

The order bars federal agencies from funding, facilitating, or assisting in medical interventions aimed at chemically or surgically altering the sex characteristics of minors.

The update on progress includes restoring scientific integrity. A major focus of the order is stopping the reliance on the World Professional Association for Transgender Health’s (WPATH) “Standards of Care Version 8.” The White House report says these standards were shaped by political influence rather than empirical evidence, and that Admiral Rachel Levine, who was Biden’s Assistant Secretary for Health, pressured WPATH to lower age thresholds for surgical procedures on children.

Under President Trump’s directive, the Department of Health and Human Services has rescinded guidance documents endorsing so-called “gender-affirming care” and labeled them as “pseudo-scientific.” However, a court mandated temporary reinstatement of the documents, and HHS complied but issued an emphatic disavowal.

Additionally, a team of eight leading scholars is prepared to publish within 90 days an evidence-based review of best practices for addressing gender dysphoria in children.

The report reveals allegations of politically motivated suppression of research under the Biden Administration. One major federally funded study’s results, the report claims, were withheld from the public to avoid political backlash. HHS and the National Institutes of Health have pledged to enhance data transparency and enforce stricter standards for taxpayer-funded studies.

Federal agencies are also reviewing their data collection methodologies to ensure that records reflect biological reality and provide actionable medical information.

A major change has occurred in the taxpayer funding of child experimentation. HHS canceled 215 federal grants associated with promoting gender interventions for minors, saving taxpayers an estimated $477 million. Examples include a $1.3 million grant to adapt teen pregnancy prevention programs for transgender boys and a $6 million grant to Boston Children’s Hospital for gender-diverse health intervention.

The Centers for Medicare and Medicaid Services issued a special alert to healthcare providers emphasizing the dangers associated with puberty blockers and cross-sex hormones for children, reaffirming the administration’s commitment to rigorous medical standards rooted in long-term evidence and ethical medical practice. Other health agencies have echoed similar warning.

CMS is also working to expand access to detransition care — medical and psychological support for individuals seeking to reverse prior gender-transition procedures.

At the Department of Defense, healthcare contractors have been ordered to halt coverage for gender-related interventions for minors, effective immediately.

The Office of Personnel Management will end insurance coverage for such procedures for children of federal employees beginning in 2026.

The Department of Justice has initiated investigations into entities accused of misleading the public about the risks of gender medical interventions and drafted legislation to empower affected families to pursue legal recourse. A new “Parental Rights Task Force” is being established to fight against state laws that undermine parental consent in decisions involving child medical transitions.

The administration pledged that these steps are just the beginning. “Our children deserve protection, truth, and care based on real science and the timeless principles of medicine — not ideology or profit motives,” the report concludes.